SunshineUK is temporarily unavailable for updates
Sunshine UK
A register of doctors' declared interests.

Rustam Al-Shahi Salman | GMC# 4067993

  • The University of Edinburgh
  • Professor of clinical neurology
Add a declaration

Declaration on 17 August 2026

Declaration period: 2026

Main employment

  • Type: NHS
  • Details: Honorary consultant neurologist / NHS Lothian

Consultancy

  • Relates to: Pharmaceutical companies
  • Income band: £2,000 to under £5,000
  • Details: Bioxodes, Novartis, GSK (paid to The University of Edinburgh)

Academic

  • Relates to: Research grants
  • Details: The Stroke Association £441,763 (paid to The University of Edinburgh) National Institute of Health and Care Research £3,467,177 (paid to The University of Edinburgh) British Heart Foundation £2,449,548 (paid to The University of Edinburgh)

Other work

  • Relates to: Commercial relationships
  • Details: NovoNordisk, clinical trial endpoint adjudication (paid to The University of Edinburgh)

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 2 March 2024

Declaration period: 2024

Main employment

  • Type: Academic
  • Details: Professor of clinical neurology, head of the cerebrovascular reesearch group, and clinical director of Edinburgh Clinical Trials Unit / The University of Edinburgh

Consultancy

  • Relates to: Pharmaceutical companies, Other
  • Income band: £1,000 to under £2,000
  • Details: Recursion (https://www.recursion.com/), Novo Nordisk (https://www.iconplc.com/), and Population Health Research Institute (https://www.phri.ca/) paid to The University of Edinburgh.

Academic

  • Relates to: Research grants
  • Income band: £100,000+
  • Details: LEAD APPLICANT 2024-2030 | British Heart Foundation, Clinical Study Grant | Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe (ASPIRING): a pragmatic, randomised, parallel group, open, superiority, phase 3 GCRFF multinational clinical trial. Application for international coordination and UK national contributions. Ref. CS/F/22/190053 (£2,333,937, paid to The University of Edinburgh for staff salaries and consumables). 2023-2026 | Chief Scientist Office Health Improvement, Protection and Services Research Committee Project Grant | PLatform randomised controlled trial for INTracerebral Haemorrhage (PLINTH): community-based feasibility study. Ref. HIPS/22/36 (£298,985 paid to The University of Edinburgh for staff salaries, consumables, and my time).

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 26 January 2023

Declaration period: 2023

Main employment

  • Type: Academic
  • Details: Professor of clinical neurology, head of the cerebrovascular reesearch group, and clinical director of Edinburgh Clinical Trials Unit / The University of Edinburgh

Consultancy

  • Relates to: Pharmaceutical companies, Other
  • Income band: £100 to under £1,000
  • Details: Bioxodes (https://bioxodes.com/), Recursion (https://www.recursion.com/), ICON (https://www.iconplc.com/), and Population Health Research Institute (https://www.phri.ca/).

Academic

  • Relates to: Research grants
  • Details: LEAD APPLICANT 2023-2026 | Chief Scientist Office Health Improvement, Protection and Services Research Committee Project Grant | PLatform randomised controlled trial for INTracerebral Haemorrhage (PLINTH): community-based feasibility study. Ref. HIPS/22/36 (£298,985 paid to The University of Edinburgh for staff salaries, consumables, and my time). 2022-2023 | NIHR Efficacy and Mechanism Evaluation (EME) Programme Application Acceleration Award – International platform studies in precision medicine | Cavernous malformations: A Randomised Efficacy PREcision medicine Platform trial (CARE PREP). Ref. NIHR153811 (£122,685 paid to The University of Edinburgh for staff salaries and my time). 2020-2023 | NIHR Health Technology Assessment trial grant | Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. Ref. NIHR128694 (£973,835, paid to the University of Edinburgh for staff salaries, consumables, and my time). 2018-2023 | The Stroke Association Haemorrhagic Stroke Priority Programme Award | NICHE: Neuro-Inflammation after Cerebral Haemorrhage in Edinburgh. Ref. TSA PPA 2017/01 (£449,482, paid to the University of Edinburgh for staff salaries and consumables).

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 1 September 2022

Declaration period: 2022

Main employment

  • Type: Academic
  • Details: Professor of clinical neurology / The University of Edinburgh

Consultancy

  • Relates to: Pharmaceutical companies
  • Income band: £100 to under £1,000
  • Details: Recursion Pharmaceuticals (paid to The University of Edinburgh) Bioxodes (paid to The University of Edinburgh)

Academic

  • Relates to: Research grants
  • Details: LEAD APPLICANT 2022-2023 | NIHR Efficacy and Mechanism Evaluation (EME) Programme Application Acceleration Award – International platform studies in precision medicine. Ref. NIHR153811 (£122,685 paid to The University of Edinburgh for my time and travel) 2020-2023 | NIHR Health Technology Assessment trial grant | Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. Ref. NIHR128694 (£973,835, paid to the University of Edinburgh for staff salaries, consumables, and my time) 2018-2023 | The Stroke Association Haemorrhagic Stroke Priority Programme Award | NICHE: Neuro-Inflammation after Cerebral Haemorrhage in Edinburgh. Ref. TSA PPA 2017/01 (£449,482, paid to the University of Edinburgh for staff salaries and consumables) CO-APPLICANT 2023-2028 | Canadian Institutes of Health Research project grant | Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe (ASPIRING): a pragmatic, randomised, parallel group, open, phase 3, international superiority trial. Ref. 481648. ($1,265,000 CAD / £813,477, all paid to McMaster University, Canada). 2017-2022 | National Institute of Health, National Institute of Neurological Disorders and Stroke (NINDS) | Long-term outcomes in unruptured brain arteriovenous malformation patients. Ref. R01 NS099268 (£2,334,739, some of which is paid to the University of Edinburgh for staff salaries) 2021-2028 | NIHR Health Technology Assessment trial grant | Tranexamic acid for hyperacute spontaneous intracerebral haemorrhage TICH-3. Ref. NIHR129917 (£4,618,606, some of which is paid to the University of Edinburgh for my time). 2023-2025 | Chief Scientist Office Health Improvement, Protection and Services Research Committee project grant | PANACHE - A Pilot Randomised Trial Comparing Two Forms Of Absorbable Versus Non-Absorbable Sutures For Carpal Tunnel Hand Surgery. Ref. HIPS/21/61 (£302,982, some of which is paid to the University of Edinburgh for my time). 2022-2023 | Chief Scientist Office Translational Clinical Studies Committee project grant | Targeting Investigation And Treatment In Patients With Type 2 Myocardial Infarction (TARGET – Type 2): A Pilot Randomised Controlled Trial. Ref. TCS/21/31 (£258,738, some of which is paid to the University of Edinburgh for my time). 2020-2022 | British Heart Foundation Centre for Research Excellence pump priming award. Individual patient data meta-analysis of the association between peri-haematomal oedema and outcome after spontaneous intracerebral haemorrhage (£46,741, paid to the University of Edinburgh for staff salaries).

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 3 May 2022

Declaration period: 2022

Main employment

  • Type: Academic
  • Details: Professor of clinical neurology / University of Edinburgh

Academic

  • Relates to: Research grants
  • Details: LEAD APPLICANT 2020-2023 | NIHR Health Technology Assessment trial grant | Cavernomas A Randomised Effectiveness (CARE) pilot trial, to address the effectiveness of active treatment (with neurosurgery or stereotactic radiosurgery) versus conservative management in people with symptomatic brain cavernoma. Ref. NIHR128694 (£973,835, paid to the University of Edinburgh for staff salaries, consumables, and my time) 2018-2023 | The Stroke Association Haemorrhagic Stroke Priority Programme Award | NICHE: Neuro-Inflammation after Cerebral Haemorrhage in Edinburgh. Ref. TSA PPA 2017/01 (£449,482, paid to the University of Edinburgh for staff salaries and consumables) CO-APPLICANT 2017-2022 | National Institute of Health, National Institute of Neurological Disorders and Stroke (NINDS) | Long-term outcomes in unruptured brain arteriovenous malformation patients. Ref. R01 NS099268 (£2,334,739, some of which is paid to the University of Edinburgh for staff salaries) 2021-2028 | NIHR Health Technology Assessment trial grant | Tranexamic acid for hyperacute spontaneous intracerebral haemorrhage TICH-3. Ref. NIHR129917 (£4,618,606, some of which is paid to the University of Edinburgh for my time). 2023-2025 | Chief Scientist Office Health Improvement, Protection and Services Research Committee project grant | PANACHE - A Pilot Randomised Trial Comparing Two Forms Of Absorbable Versus Non-Absorbable Sutures For Carpal Tunnel Hand Surgery. Ref. HIPS/21/61 (£302,982, some of which is paid to the University of Edinburgh for my time). 2022-2023 | Chief Scientist Office Translational Clinical Studies Committee project grant | Targeting Investigation And Treatment In Patients With Type 2 Myocardial Infarction (TARGET – Type 2): A Pilot Randomised Controlled Trial. Ref. TCS/21/31 (£258,738, some of which is paid to the University of Edinburgh for my time). 2020-2022 | British Heart Foundation Centre for Research Excellence pump priming award. Individual patient data meta-analysis of the association between peri-haematomal oedema and outcome after spontaneous intracerebral haemorrhage (£46,741, paid to the University of Edinburgh for staff salaries).

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 9 July 2021

Declaration period: 2021

Consultancy

  • Relates to: Technology companies, Other
  • Income band: £1,000 to under £2,000
  • Details: Recursion Pharmaceuticals Consultancy (paid to my employer) BiovelocITA Consultancy (paid to my employer) Population Health Research Institute Consultancy (paid to my employer)

Academic

  • Relates to: Research grants, Other
  • Income band: £100,000+
  • Details: GE Healthcare investigator sponsored study (paid to my employer) British Heart Foundation (paid to my employer) The Stroke Association (paid to my employer) NIHR Helath Technology Assessment (paid to my employer) NIH NINDS (paid to my employer) Donations from patients, their carers, their relatives, and members of the public (paid to my employer)

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 29 May 2019

Research grants paid by private institutions to your department

  • Company: BiovelocITA · Reason for receipt of fees: Consultancy, paid to my employer · Total amount received: £1,000 to under £2,000
  • Company: Recursion Pharmaceuticals · Reason for receipt of fees: Consultancy, paid to my employer · Total amount received: £100 to under £1,000
  • Company: GE Healthcare · Reason for receipt of fees: Investigator sponsored study, paid to my employer · Total amount received: £50,000 to under £100,000

Other declarations

I am employed by the University of Edinburgh and NHS Lothian. My Research to Understand Stroke due to Haemorrhage (www.RUSH.ed.ac.uk) programme's donation fund (held by the University of Edinburgh) has received an award from the BUPA UK Foundation and charitable donations from patients, their carers, their relatives and members of the public.

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 10 September 2017

Other sources of income or benefits from other organisations relevant to medical practice

  • Company: Bio Med Central · Reason for receipt of fees: Senior editor for the journal "Trials" · Total amount received: £100 to under £1,000

Research grants paid by private institutions to your department

  • Company: GE Healthcare · Reason for receipt of fees: Investigator sponsored study of the PET radiotracer 18F-Flutemetamol for the detection of cerebral amyloid angiopathy · Total amount received: £50,000 to under £100,000

Other declarations

I am an investigator on research grants paid to the University of Edinburgh from: the Medical Research Council, British Heart Foundation, Wellcome Trust, The Stroke Association, NIH National Institute of Neurological Disorders and Stroke, Chest Heart & Stroke Scotland, and the Chief Scientist Office of the Scottish Government. My Research to Understand Stroke due to Haemorrhage (www.RUSH.ed.ac.uk) programme's donation fund (held by the University of Edinburgh) has received an award from the BUPA UK Foundation and charitable donations from patients, their carers, their relatives and members of the public.

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 21 February 2017

Research grants paid by private institutions to your department

  • Company: GE Healthcare · Reason for receipt of fees: Grant paid to the University of Edinburgh for an investigator sponsored study of the PET radiotracer 18F-Flutemetamol for the detection of cerebral amyloid angiopathy in association with intracerebral · Total amount received: £50,000 to under £100,000

Other declarations

My salary is mostly paid by the University of Edinburgh and the U.K. National Health Service (which is still just about a state healthcare service in Scotland). I am the chief investigator on research grants, paid to the University of Edinburgh, from: the British Heart Foundation, The Stroke Association, Chest Heart & Stroke Scotland, and The Academy of Medical Sciences INSPIRE scheme.

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 24 February 2016

Research grants paid by private institutions to your department

  • Company: GE Healthcare · Reason for receipt of fees: Investigator sponsored study of the PET radiotracer 18F-Flutemetamol for the detection of cerebral amyloid angiopathy in association with intracerebral haemorrhage · Total amount received: £50,000 to under £100,000

Other declarations

My salary is mostly paid by the U.K. Medical Research Council (a state funding body) via the University of Edinburgh and the U.K. National Health Service (which is still just about a state healthcare service in Scotland). I am the chief investigator on research grants, paid to the University of Edinburgh, from: the U.K. Medical Research Council, British Heart Foundation, The Stroke Association, Chest Heart & Stroke Scotland, and The Academy of Medical Sciences INSPIRE scheme.

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration on 20 February 2016

Other declarations

My salary is mostly paid by the U.K. Medical Research Council (a state funding body) via the University of Edinburgh and the U.K. National Health Service (still just about a state healthcare service). I have active research grants from the U.K. British Heart Foundation, Medical Research Council, and Chest Heart & Stroke Scotland.

Something wrong with this declaration? Contact team@sunshineuk.org to let them know.